169 related articles for article (PubMed ID: 21271316)
1. The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation.
Shoyele SA; Sivadas N; Cryan SA
AAPS PharmSciTech; 2011 Mar; 12(1):304-11. PubMed ID: 21271316
[TBL] [Abstract][Full Text] [Related]
2. The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process.
Poursina N; Vatanara A; Rouini MR; Gilani K; Najafabadi AR
Acta Pharm; 2016 Jun; 66(2):207-18. PubMed ID: 27279064
[TBL] [Abstract][Full Text] [Related]
3. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
[TBL] [Abstract][Full Text] [Related]
4. Systemic delivery of parathyroid hormone (1-34) using spray freeze-dried inhalable particles.
Poursina N; Vatanara A; Rouini MR; Gilani K; Rouholamini Najafabadi A
Pharm Dev Technol; 2017 Sep; 22(6):733-739. PubMed ID: 26708720
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
Karimi K; Katona G; Csóka I; Ambrus R
J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
[TBL] [Abstract][Full Text] [Related]
6. Protein inhalation powders: spray drying vs spray freeze drying.
Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
[TBL] [Abstract][Full Text] [Related]
7. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics.
Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Vehring R
Eur J Pharm Biopharm; 2022 Aug; 177():308-322. PubMed ID: 35905804
[TBL] [Abstract][Full Text] [Related]
8. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.
Arte KS; Tower CW; Mutukuri TT; Chen Y; Patel SM; Munson EJ; Tony Zhou Q
Int J Pharm; 2024 Jan; 650():123698. PubMed ID: 38081559
[TBL] [Abstract][Full Text] [Related]
9. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
[TBL] [Abstract][Full Text] [Related]
10. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
[TBL] [Abstract][Full Text] [Related]
11. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
Minne A; Boireau H; Horta MJ; Vanbever R
Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
[TBL] [Abstract][Full Text] [Related]
13. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats.
Codrons V; Vanderbist F; Verbeeck RK; Arras M; Lison D; Préat V; Vanbever R
J Pharm Sci; 2003 May; 92(5):938-50. PubMed ID: 12712413
[TBL] [Abstract][Full Text] [Related]
15. Spray-Freeze Drying: a Suitable Method for Aerosol Delivery of Antibodies in the Presence of Trehalose and Cyclodextrins.
Pouya MA; Daneshmand B; Aghababaie S; Faghihi H; Vatanara A
AAPS PharmSciTech; 2018 Jul; 19(5):2247-2254. PubMed ID: 29740758
[TBL] [Abstract][Full Text] [Related]
16. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.
Bosquillon C; Lombry C; Préat V; Vanbever R
J Control Release; 2001 Feb; 70(3):329-39. PubMed ID: 11182203
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
Wu X; Zhang W; Hayes D; Mansour HM
Int J Nanomedicine; 2013; 8():1269-83. PubMed ID: 23569375
[TBL] [Abstract][Full Text] [Related]
18. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
Yu J; Chan HK; Gengenbach T; Denman JA
Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
[TBL] [Abstract][Full Text] [Related]
19. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
Amaro MI; Tajber L; Corrigan OI; Healy AM
Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469
[TBL] [Abstract][Full Text] [Related]
20. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.
Ramezani V; Vatanara A; Seyedabadi M; Nabi Meibodi M; Fanaei H
Drug Dev Ind Pharm; 2017 Jul; 43(7):1103-1111. PubMed ID: 28276783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
